RESUMEN
In this review, we examined a 45-year-old Asian man who had been diagnosed with florid osseous dysplasia (FOD) ofthe mandible and acute perimandibular cellulitis. This presentation occurred after a history of off-and-on swellingsof the jaw and multiple treatments received at another hospital. An aggressive resection of the jaw was planned;however, the patient denied the treatment and came to our clinic to seek a second opinion. The patient was successfullytreated by conservative surgery and antibiotic treatment with preservation of the jaw integrity and themandibular neurovascular canal. Intraoperatively, a piece of a calcified mass was removed and submitted for histopathologicalexamination. The specimen showed woven bone and densely sclerotic mass of calcified materialsexhibiting reversal lines and inflammatory cell infiltration of the connective tissue. The definitive diagnosis wasFOD with a secondary infection. Treatments for FOD were discussed (AU)
No disponible
Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Celulitis/complicaciones , Enfermedades Maxilomandibulares/complicaciones , Enfermedad AgudaRESUMEN
En los últimos años, en la literatura se han recogido diversas series de osteoquimionecrosis asociadas a bifosfonatos. En algunos pacientes que tomaban bifosfonatos se observó dolor, exposición ósea y osteitis tras una exodoncia u espontáneamente. Presentamos nuestra experiencia desde nuestro servicio de cirugía oral y maxilofacial en el seguimiento de 15 pacientes que han presentado esta patología, incluyendo nuestro protocolo diagnóstico-terapéutico (AU)
Recently in the literature many papers concerning bone osteonecrosis of the jaws (BON) have appeared related with Biphosphonates. Some of the patients taking Biphosphonates developped oral lesions which are similar in appearance to those of radiation-induced osteonecrosis. Clinically, they appear as ragged oral mucosal ulcerations that expose underlying bone and often are extremely painful, many times related with previous manipulation and sometimes spontaneously. The lesions are persistent and do not respond to conventional treatment modalities. We present our experience and recommendations which are based on expert opinion from the literature, the guidelines for the diagnoses and management of care of patients who develop BON; the prevention of this complication based on current knowledge; and recommendations for the routine dental treatment of patients receiving bisphosphonate therapy (AU)